Article info
PDFElectronic pages
Constrictive pericarditis and pleuropulmonary fibrosis secondary to cabergoline treatment for Parkinson’s disease
- Correspondence to:
Dr Mandie Townsend
Department of Cardiology, Taunton and Somerset Hospital, Musgrove Park, Taunton TA1 5DA, UK; mandietownsendyahoo.co.uk
Citation
Constrictive pericarditis and pleuropulmonary fibrosis secondary to cabergoline treatment for Parkinson’s disease
Publication history
- Accepted March 17, 2004
- First published July 14, 2004.
Online issue publication
May 30, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 by Heart